MIRM
Mirum Pharmaceuticals Inc
89.40$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +45.7% | -0.5% | +12.5% | +16.1% | +10.0% | +12.2% | +14.5% | +4.1% | +12.0% | +7.4% | +10.2% | – | |
| – | +144.6% | -28.7% | +13.4% | +2.9% | +9.5% | +1.0% | +1.8% | +9.0% | +11.0% | +1.9% | +5.1% | – | |
| – | +18.8% | +15.4% | +12.2% | +20.7% | +10.2% | +15.6% | +17.8% | +3.0% | +12.2% | +8.6% | +11.4% | – | |
| – | +18.4% | +4.2% | +1.4% | -2.9% | +38.8% | +4.6% | +0.0% | -6.7% | +19.0% | +91.6% | -7.5% | – | |
| – | +9.2% | +14.4% | -9.6% | +22.6% | -10.3% | +27.3% | +9.7% | -2.2% | +19.7% | +30.0% | -15.4% | – | |
| – | +23.1% | +1.0% | +5.2% | +0.5% | +22.6% | +2.9% | +5.4% | -4.1% | +19.4% | +55.1% | -3.0% | – | |
| – | – | – | – | – | – | – | – | – | -275.5% | – | – | – | |
| – | -0.3% | +0.4% | -0.2% | +0.5% | -0.2% | +0.5% | -0.2% | +0.5% | -0.2% | +0.5% | -27.6% | – | |
| – | – | – | – | – | – | – | – | – | -287.8% | – | – | – | |
| – | -9.6% | +177.3% | +1.8% | -45.4% | -266.0% | – | -60.9% | -165.2% | – | -38.1% | +255.6% | – | |
| – | – | – | – | – | – | – | – | – | -297.2% | – | – | – | |
| – | – | – | – | – | – | – | – | +116.4% | -48.0% | -16,646.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.